Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.

Li X, Zhang J, Huang J, Ma A, Yang J, Li W, Wu Z, Yao C, Zhang Y, Yao W, Zhang B, Gao R; Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group.

J Am Coll Cardiol. 2013 Sep 17;62(12):1065-72. doi: 10.1016/j.jacc.2013.05.035. Epub 2013 Jun 7.

PMID:
23747768
[PubMed - indexed for MEDLINE]
Free Article
2.

Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

Toblli JE, Lombraña A, Duarte P, Di Gennaro F.

J Am Coll Cardiol. 2007 Oct 23;50(17):1657-65.

PMID:
17950147
[PubMed - indexed for MEDLINE]
Free Article
3.

Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.

Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL Jr.

Am Heart J. 2010 Apr;159(4):532-538.e1. doi: 10.1016/j.ahj.2010.01.005.

PMID:
20362709
[PubMed - indexed for MEDLINE]
4.

Cardiotonic modulation in heart failure: insights from traditional Chinese medicine.

Tang WH, Huang Y.

J Am Coll Cardiol. 2013 Sep 17;62(12):1073-4. doi: 10.1016/j.jacc.2013.05.028. Epub 2013 Jun 7. No abstract available.

PMID:
23747774
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).

Hou YZ, Wang S, Zhao ZQ, Wang XL, Li B, Soh SB, Mao JY.

Trials. 2013 May 14;14:138. doi: 10.1186/1745-6215-14-138.

PMID:
23672353
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.

Januzzi JL Jr, Rehman SU, Mohammed AA, Bhardwaj A, Barajas L, Barajas J, Kim HN, Baggish AL, Weiner RB, Chen-Tournoux A, Marshall JE, Moore SA, Carlson WD, Lewis GD, Shin J, Sullivan D, Parks K, Wang TJ, Gregory SA, Uthamalingam S, Semigran MJ.

J Am Coll Cardiol. 2011 Oct 25;58(18):1881-9. doi: 10.1016/j.jacc.2011.03.072.

PMID:
22018299
[PubMed - indexed for MEDLINE]
Free Article
7.

Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.

Shaikh K, Hanif B, Siddique AA, Shaikh MY, Khan MN.

J Coll Physicians Surg Pak. 2012 Dec;22(12):751-5. doi: 12.2012/JCPSP.751755.

PMID:
23217478
[PubMed - indexed for MEDLINE]
8.

Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.

Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP; TIME-CHF Investigators.

Circ Heart Fail. 2014 Jan;7(1):131-9. doi: 10.1161/CIRCHEARTFAILURE.113.000527. Epub 2013 Dec 18.

PMID:
24352403
[PubMed - indexed for MEDLINE]
9.

[Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].

Wu YR, Chen SB, Huang MR, Zhang YQ, Sun K, Chen S.

Zhonghua Er Ke Za Zhi. 2005 Mar;43(3):161-4. Chinese.

PMID:
15833183
[PubMed - indexed for MEDLINE]
10.

Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.

Bhardwaj A, Rehman SU, Mohammed AA, Gaggin HK, Barajas L, Barajas J, Moore SA, Sullivan D, Januzzi JL.

Am Heart J. 2012 Nov;164(5):793-799.e1. doi: 10.1016/j.ahj.2012.08.015.

PMID:
23137512
[PubMed - indexed for MEDLINE]
11.

[Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].

Wang F, Xu ZM, Wang L, Bian WY, Jia X, Duan B, Li W, Li YS.

Zhonghua Nei Ke Za Zhi. 2005 Jul;44(7):490-4. Chinese.

PMID:
16080835
[PubMed - indexed for MEDLINE]
12.

Does NT-proBNP remain a sensitive biomarker for chronic heart failure after administration of a beta-blocker?

Li N, Li Y, Wang F, Jiang W, Huang J, Xu Z, Hua L, Hua C, Huang Y, Wu Y, Li F.

Clin Cardiol. 2007 Sep;30(9):469-74.

PMID:
17803204
[PubMed - indexed for MEDLINE]
13.

The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.

Karabulut A, Kaplan A, Aslan C, Iltumur K, Toprak G, Toprak N.

Acta Cardiol. 2005 Dec;60(6):631-8.

PMID:
16385925
[PubMed - indexed for MEDLINE]
14.

N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.

Felker GM, Whellan D, Kraus WE, Clare R, Zannad F, Donahue M, Adams K, McKelvie R, Piña IL, O'Connor CM; HF-ACTION Investigators.

Am Heart J. 2009 Oct;158(4 Suppl):S37-44. doi: 10.1016/j.ahj.2009.07.011.

PMID:
19782787
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).

Maeder MT, Rickenbacher P, Rickli H, Abbühl H, Gutmann M, Erne P, Vuilliomenet A, Peter M, Pfisterer M, Brunner-La Rocca HP; TIME-CHF Investigators.

Eur J Heart Fail. 2013 Oct;15(10):1148-56. doi: 10.1093/eurjhf/hft076. Epub 2013 May 8.

PMID:
23657728
[PubMed - indexed for MEDLINE]
16.

Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1.

Frantz RP, McDevitt S, Walker S.

J Heart Lung Transplant. 2012 Aug;31(8):811-6. doi: 10.1016/j.healun.2012.04.005.

PMID:
22759797
[PubMed - indexed for MEDLINE]
17.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

PMID:
17996563
[PubMed - indexed for MEDLINE]
Free Article
18.

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group.

J Am Coll Cardiol. 2009 Nov 10;54(20):1850-9. doi: 10.1016/j.jacc.2009.06.041.

PMID:
19892235
[PubMed - indexed for MEDLINE]
Free Article
19.

Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients.

Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.

J Heart Lung Transplant. 2008 Nov;27(11):1251-6. doi: 10.1016/j.healun.2008.07.030.

PMID:
18971099
[PubMed - indexed for MEDLINE]
20.

Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure.

Yu CM, Fung JW, Zhang Q, Chan CK, Chan I, Chan YS, Kong SL, Sanderson JE, Lam CW.

J Card Fail. 2005 Jun;11(5 Suppl):S42-6.

PMID:
15948100
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk